Malone B et al. |
Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product. |
1985 |
J. Biol. Chem. |
pmid:3918041
|
Juhan-Vague I et al. |
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro. |
1985 |
Thromb. Res. |
pmid:3923649
|
Steiner M et al. |
Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3936503
|
Avdonin PV et al. |
Stimulation of high-affinity hormone-sensitive GTPase of human platelets by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphocholine (platelet activating factor). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2994653
|
Maridonneau-Parini I et al. |
Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2994661
|
Zukowska-Grojec Z et al. |
The adrenergic system and the cardiovascular effects of platelet activating factor (1-0-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine) in SHR and WKY rats. |
1985 |
Clin Exp Hypertens A |
pmid:2994912
|
Shen TY et al. |
The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor. |
1985 |
Int J Tissue React |
pmid:2997065
|
Sánchez Crespo M et al. |
Synthesis of platelet-activating factor from human polymorphonuclear leukocytes: regulation and pharmacological approaches. |
1985 |
Int J Tissue React |
pmid:2997066
|
Proll MA et al. |
Phosphatidate and monooleylphosphatidate inhibition of fibroblast adenylate cyclase is mediated by the inhibitory coupling protein, Ni. |
1985 |
Mol. Pharmacol. |
pmid:2997592
|
MacIntyre DE et al. |
Endogenous and pharmacological mechanisms for the regulation of human platelet cytosolic free Ca2+. |
1985 |
Nouv Rev Fr Hematol |
pmid:2997706
|
Lachachi H et al. |
Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2998370
|
Wal F et al. |
PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin. |
1985 |
Thromb. Haemost. |
pmid:3992525
|
Khan SN et al. |
Response to platelet-activating factor of platelets from patients with multiple sclerosis. |
1985 |
Acta Neurol. Scand. |
pmid:3993327
|
Tamargo J et al. |
Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles. |
1985 |
Eur. J. Pharmacol. |
pmid:3996472
|
Terashita Z et al. |
Is platelet activating factor (PAF) a mediator of endotoxin shock? |
1985 |
Eur. J. Pharmacol. |
pmid:3996473
|
Ohno M et al. |
An enantioselective synthesis of platelet-activating factors, their enantiomers, and their analogues from D- and L-tartaric acids. |
1985 |
Chem. Pharm. Bull. |
pmid:4017109
|
O'Neill C et al. |
Maternal blood platelet physiology and luteal-phase endocrinology as a means of monitoring pre- and postimplantation embryo viability following in vitro fertilization. |
1985 |
J In Vitro Fert Embryo Transf |
pmid:4020241
|
Heymans F et al. |
Structure-activity relationship in PAF-acether. 2. rac-1-O-Octadecyl-2-O-acetyl-3-O-[gamma-(dimethylamino)propyl]glycerol . |
1985 |
J. Med. Chem. |
pmid:4020830
|
Touqui L et al. |
1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle. |
1985 |
Biochim. Biophys. Acta |
pmid:3967037
|
Weber N and Benning H |
Ether glycerolipids: novel substrates for studying specificity of enzymes involved in glycerolipid biosynthesis in higher plants. |
1985 |
Eur. J. Biochem. |
pmid:3967662
|
Mallet AI and Cunningham FM |
Structural identification of platelet activating factor in psoriatic scale. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970690
|
Valone FH |
Inhibition of binding of the platelet-activating factor AGEPC to platelets by the AGEPC analog rac-3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl 2-thiazolioethyl phosphate (CV-3988). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970703
|
Ardaillou N et al. |
Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. |
1985 |
Am. J. Physiol. |
pmid:3918460
|
Suemune H et al. |
Synthetic studies on platelet-activating factor (PAF). |
1985 |
Chem. Pharm. Bull. |
pmid:4028291
|
Parente L et al. |
The release of lyso-PAF from guinea-pig lungs. |
1985 |
Eur. J. Pharmacol. |
pmid:4029263
|
Lee TC |
Biosynthesis of platelet activating factor. Substrate specificity of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase in rat spleen microsomes. |
1985 |
J. Biol. Chem. |
pmid:4030776
|
Wissner A et al. |
Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone. |
1985 |
J. Med. Chem. |
pmid:4032422
|
Pritchard PH et al. |
The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease). |
1985 |
Blood |
pmid:4063532
|
Wissner A et al. |
Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group. |
1985 |
J. Med. Chem. |
pmid:4032438
|
Wimberly HC et al. |
Functional and biochemical characterization of immunologically derived equine platelet-activating factor. |
1985 |
Vet. Pathol. |
pmid:4035942
|
MacIntyre DE et al. |
Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca2+ flux in human platelets. |
1985 |
FEBS Lett. |
pmid:2981715
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin. |
1985 |
Arch. Biochem. Biophys. |
pmid:4037794
|
Sugiura T et al. |
Transacylation of 1-O-alkyl-SN-glycero-3-phosphocholine (lyso platelet-activating factor) and 1-O-alkenyl-SN-glycero-3-phosphoethanolamine with docosahexaenoic acid (22:6 omega 3). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2935146
|
Hemker HC and Béguin S |
The generation of thrombin in whole plasma. Biochemical possibilities and physiological realities. |
1985 |
Verh. K. Acad. Geneeskd. Belg. |
pmid:4090648
|
Hallam TJ et al. |
Relationship between cytoplasmic free calcium and myosin light chain phosphorylation in intact platelets. |
1985 |
Biochem. J. |
pmid:4091795
|
Fouque F and Vargaftig BB |
Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine. |
1985 |
J Pharmacol |
pmid:4094442
|
Bergelson LD et al. |
Influence of platelet activation factor and prostaglandins on cholesterol esterification in human plasma. |
1985 |
FEBS Lett. |
pmid:4043408
|
Kilpatrick JM and Virella G |
Inhibition of platelet-activating factor by rabbit C-reactive protein. |
1985 |
Clin. Immunol. Immunopathol. |
pmid:4042435
|
Monnens L et al. |
Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood. |
1985 |
Clin. Nephrol. |
pmid:4042442
|
Vigo C |
Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. |
1985 |
J. Biol. Chem. |
pmid:3919022
|
Armstrong RA et al. |
Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha. |
1985 |
Prostaglandins |
pmid:2988022
|
Sugiura T and Waku K |
CoA-independent transfer of arachidonic acid from 1,2-diacyl-sn-glycero-3-phosphocholine to 1-O-alkyl-sn-glycero-3-phosphocholine (lyso platelet-activating factor) by macrophage microsomes. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3919727
|
Dewald B and Baggiolini M |
Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2985075
|
Wasserman SI |
The mast cell and theophylline in asthma. |
1985 |
Am. J. Med. |
pmid:3002176
|
Orlov SM et al. |
[Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs]. |
1985 |
Biokhimiia |
pmid:2408682
|
Hallam TJ and Rink TJ |
Agonists stimulate divalent cation channels in the plasma membrane of human platelets. |
1985 |
FEBS Lett. |
pmid:2408921
|
O'Neill C et al. |
Maternal recognition of pregnancy prior to implantation: methods for monitoring embryonic viability in vitro and in vivo. |
1985 |
Ann. N. Y. Acad. Sci. |
pmid:2409860
|
Sage SO and Rink TJ |
Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets. |
1985 |
FEBS Lett. |
pmid:2410292
|
Grandel KE et al. |
Association of platelet-activating factor with primary acquired cold urticaria. |
1985 |
N. Engl. J. Med. |
pmid:2410790
|
Tou J |
Platelet-activating factor promotes arachidonate incorporation into phosphatidylinositol and phosphatidylcholine in neutrophils. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3921017
|